Wells Fargo’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Hold
0
-$33 7115
2024
Q1
Hold
0
6959
2023
Q4
Hold
0
6776
2023
Q3
Hold
0
6638
2023
Q2
Hold
0
6555
2023
Q1
Hold
0
6662
2022
Q4
Hold
0
6403
2022
Q3
Hold
0
6152
2022
Q2
Hold
0
6318
2022
Q1
Hold
0
6522
2021
Q4
Sell
-1
Closed -$83.4K 6751
2021
Q3
$77K Hold
1
﹤0.01% 5477
2021
Q2
$96K Hold
1
﹤0.01% 5316
2021
Q1
$161K Sell
1
-2
-67% -$439K ﹤0.01% 5256
2020
Q4
$472K Buy
+3
New +$464K ﹤0.01% 4564
2020
Q3
Hold
0
5486
2020
Q2
Hold
0
5479
2020
Q1
Hold
0
6412
2018
Q3
Hold
0
-$1K 6463
2018
Q2
Hold
0
6242

Other funds holding GNPX

Wells Fargo's GNPX Position: Q2 2024 in Review

Wells Fargo held its Genprex (GNPX) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7115.

Wells Fargo first reported a position in GNPX in Q4 2020 and has held it in 4 quarters since. The position peaked at $472K in Q4 2020. 8 funds tracked by Wall St. Rank hold GNPX as of Q2 2024.

  • Wells Fargo held 0 shares of Genprex worth $0 as of Q2 2024.
  • Wells Fargo left its Genprex share count unchanged in Q2 2024.
  • Genprex made up ﹤0.01% of Wells Fargo's portfolio in Q2 2024, its #7115 holding.
  • Wells Fargo first reported a position in Genprex in Q4 2020 and has held it in 4 quarters since.
  • Wells Fargo's Genprex position peaked at $472K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.